Valuation: Biogen Inc.

Market Cap 30.8B 26.68B 24.87B 22.87B 43.18B 2,929B 43.66B 292B 115B 1,465B 116B 113B 4,853B P/E 2026 *
37.9x
P/E 2027 * 18.4x
Enterprise Value 35.88B 31.08B 28.97B 26.64B 50.3B 3,412B 50.86B 340B 134B 1,707B 135B 132B 5,654B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.14x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.83%
1 week-1.57%
Current month+1.47%
1 month-1.21%
3 months+8.89%
6 months+11.10%
Current year+17.02%
1 week 199.58
Extreme 199.58
212.18
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 127
Extreme 127
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Head of Human Resources

8,025 0.0055%
13/2/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-1.57%+54.97%-24.07% 30.8B
+1.04%+9.93%+34.14%-1.32% 75.96B
+2.64%-8.39%+24.13%+188.08% 49.03B
+1.02%-3.74%-7.47%+21.83% 47.88B
+1.42%+9.32%-50.68%-50.72% 43.39B
-0.64%-5.82%+54.00%+84.41% 24.45B
-1.22%+2.48%+103.28%-44.82% 22.75B
+4.15%+0.44%-2.80%+175.30% 19.24B
-0.01%-1.87%+66.59%+164.79% 16.04B
+1.05%-6.85%+60.29%+117.79% 15.87B
Average +0.91%-1.38%+33.65%+63.13% 34.54B
Weighted average by Cap. +1.06%+0.26%+24.77%+46.77%

Financials

2026 *2027 *
Net sales 10.42B 9.03B 8.41B 7.74B 14.61B 991B 14.77B 98.89B 38.81B 496B 39.15B 38.28B 1,642B 10.62B 9.2B 8.58B 7.89B 14.89B 1,010B 15.06B 101B 39.56B 505B 39.91B 39.03B 1,674B
Net income 953M 825M 769M 708M 1.34B 90.62B 1.35B 9.04B 3.55B 45.34B 3.58B 3.5B 150B 1.9B 1.64B 1.53B 1.41B 2.66B 181B 2.69B 18.02B 7.07B 90.36B 7.13B 6.98B 299B
Net Debt 5.08B 4.4B 4.1B 3.77B 7.12B 483B 7.2B 48.21B 18.92B 242B 19.08B 18.66B 801B 2.57B 2.22B 2.07B 1.91B 3.6B 244B 3.64B 24.35B 9.56B 122B 9.64B 9.43B 404B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/08/26 US$205.81 -1.27% 487,726
04/08/26 US$208.45 +3.29% 1,205,704
03/08/26 US$201.82 -0.56% 940,993
31/07/26 US$202.95 -2.40% 1,062,258
30/07/26 US$207.93 -0.62% 892,938
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
208.45USD
Average target price
235.32USD
Spread / Average Target
+12.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock